NCT05585554View on ClinicalTrials.gov

Locally Advanced Pancreatic Cancer Treated With ABLAtivE Stereotactic MRI-guided Adaptive Radiation Therapy

NANot yet recruitingINTERVENTIONAL
Enrollment

267

Participants

Timeline

Start Date

July 31, 2023

Primary Completion Date

August 31, 2028

Study Completion Date

December 31, 2028

Conditions
Pancreatic Cancer
Interventions
RADIATION

MRIdian

Stereotactic MRI-guided On-table Adaptive Radiation Therapy delivered on MRIdian linac

All Listed Sponsors
lead

Viewray Inc.

INDUSTRY

NCT05585554 - Locally Advanced Pancreatic Cancer Treated With ABLAtivE Stereotactic MRI-guided Adaptive Radiation Therapy | Biotech Hunter | Biotech Hunter